SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,823,229 | -12.0% | 1,148,591 | 0.0% | 1.02% | -2.5% |
| Q1 2024 | $24,809,566 | +62.1% | 1,148,591 | +30.3% | 1.05% | +28.0% |
| Q4 2023 | $15,305,975 | +76.7% | 881,173 | 0.0% | 0.82% | +42.3% |
| Q3 2023 | $8,661,931 | +78.7% | 881,173 | 0.0% | 0.58% | +99.0% |
| Q2 2023 | $4,846,452 | -11.3% | 881,173 | 0.0% | 0.29% | -27.0% |
| Q1 2023 | $5,463,273 | -59.3% | 881,173 | 0.0% | 0.40% | -52.6% |
| Q4 2022 | $13,437,888 | +54.5% | 881,173 | 0.0% | 0.84% | +24.6% |
| Q3 2022 | $8,697,000 | -16.7% | 881,173 | 0.0% | 0.67% | -32.0% |
| Q2 2022 | $10,442,000 | -37.6% | 881,173 | 0.0% | 0.98% | -31.0% |
| Q1 2022 | $16,742,000 | – | 881,173 | – | 1.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 500,214 | $9,504,066 | 9.16% |
| TCG Crossover Management, LLC | 3,295,350 | $62,611,650 | 6.52% |
| M28 Capital Management LP | 185,100 | $3,516,900 | 4.56% |
| Nextech Invest Ltd. | 952,400 | $18,095,600 | 3.04% |
| Lombard Odier Asset Management (USA) Corp | 2,405,998 | $36,759,464 | 2.72% |
| Redmile Group, LLC | 2,014,296 | $38,271,624 | 2.31% |
| Logos Global Management LP | 1,476,061 | $28,045,159 | 2.28% |
| 5AM Venture Management, LLC | 476,200 | $9,047,800 | 2.02% |
| Vivo Capital, LLC | 1,105,454 | $21,003,626 | 1.94% |
| First Turn Management, LLC | 537,338 | $10,209,422 | 1.66% |